NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Capital Work in Progress | - | - | - | - | - |
What is the latest Capital Work in Progress ratio of NATH BIOGENES (INDIA) ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2013 | - |
How is Capital Work in Progress of NATH BIOGENES (INDIA) Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2013 | - | - | |
Compare Capital Work in Progress of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹297.4 Cr | 3.8% | -8.3% | -14.1% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,796.5 Cr | -1.4% | -9.1% | -27% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,106.4 Cr | 4.4% | -5.8% | 10.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,895.5 Cr | 0.6% | -8.5% | -21.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,102.7 Cr | -6.5% | -14.2% | -26.4% | Stock Analytics | |
| INDO US BIOTECH | ₹272.8 Cr | 16.7% | -3.5% | -40.7% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 3.8% |
-8.3% |
-14.1% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses